Seres Therapeutics, Inc. (47)
Browse by Contract Category
Contracts
-
First Amendment to Lease, dated December 9, 2022, by and between Seres Therapeutics, Inc. and BMR-Sidney Research Campus, LLC (f/k/a BMR 200-Sidney Street LLC)
(Filed With SEC on December 14, 2022)
-
Supply Agreement, dated September 15, 2015, by and between Seres Therapeutics, Inc. and GenIbet BioPharmaceuticals, SA, as amended
(Filed With SEC on November 2, 2022)
-
Non-Employee Director Compensation Program
(Filed With SEC on August 3, 2022)
-
Form of Affiliate Purchase Agreement
(Filed With SEC on June 30, 2022)
-
Amendment No. 1 to License Agreement, dated March 24, 2022, by and between the Registrant and NHSc Pharma Partners
(Filed With SEC on May 4, 2022)
-
Long Term Manufacturing Agreement, dated November 8, 2021, by and between the Registrant and BacThera AG
(Filed With SEC on March 1, 2022)
-
Placement Agency Agreement, dated June 29, 2022, by and between Seres Therapeutics, Inc. and J.P. Morgan Securities LLC
(Filed With SEC on June 30, 2022)
-
Form of Non-Affiliate Purchase Agreement
(Filed With SEC on June 30, 2022)
-
Second Amendment to Loan and Security Agreement, dated February 24, 2022 by and between the Registrant and Hercules Capital, Inc
(Filed With SEC on March 1, 2022)
-
Employment Agreement, dated January 5, 2022, by and between the Registrant and Paula Cloghessy
(Filed With SEC on March 1, 2022)
-
License Agreement, dated July 1, 2021, by and between the Registrant and NHSc Pharma Partners
(Filed With SEC on November 10, 2021)
-
Non-Employee Director Compensation Program
(Filed With SEC on November 10, 2021)
-
Letter Agreement, dated November 4, 2021, by and between the Registrant and David S. Ege, Ph.D
(Filed With SEC on November 10, 2021)
-
Non-Employee Director Compensation Program
(Filed With SEC on August 3, 2021)
-
Amended and Restated Employment Agreement, dated as of January 29, 2021, by and between the Registrant and David S. Ege, Ph.D
(Filed With SEC on August 3, 2021)
-
Sales Agreement, dated as of May 21, 2021, between Seres Therapeutics, Inc. and Cowen and Company, LLC
(Filed With SEC on May 21, 2021)
-
Employment Agreement, dated May 10, 2021, by and between Seres Therapeutics, Inc. and David Arkowitz
(Filed With SEC on May 20, 2021)
-
Description of Capital Stock
(Filed With SEC on March 2, 2021)
-
Amended and Restated Employment Agreement, dated January 29, 2021, by and between the Registrant and Lisa von Moltke, M.D
(Filed With SEC on March 2, 2021)
-
Amended and Restated Employment Agreement, dated January 29, 2021, by and between the Registrant and Teresa L. Young
(Filed With SEC on March 2, 2021)
-
Amended and Restated Employment Agreement, dated January 29, 2021, by and between the Registrant and David S. Ege, Ph.D
(Filed With SEC on March 2, 2021)
-
Non-Employee Director Compensation Program
(Filed With SEC on March 2, 2021)
-
2015 Incentive Award Plan and forms of award agreements thereunder
(Filed With SEC on March 2, 2021)
-
Second Amended and Restated Employment Agreement, dated as of January 29, 2021, between Seres Therapeutics, Inc. and Matthew R. Henn, Ph.D
(Filed With SEC on February 1, 2021)
-
Amended and Restated Employment Agreement, dated as of January 29, 2021, between Seres Therapeutics, Inc. and Thomas J. DesRosier
(Filed With SEC on February 1, 2021)
-
Amended and Restated Employment Agreement, dated as of January 29, 2021, between Seres Therapeutics, Inc. and Eric D. Shaff
(Filed With SEC on February 1, 2021)
-
Employment Agreement, dated October 13, 2020, by and between the Registrant and David S Ege
(Filed With SEC on November 9, 2020)
-
Securities Purchase Agreement, dated August 12, 2020, between the Company and Socit des Produits Nestl S.A
(Filed With SEC on August 14, 2020)
-
Underwriting Agreement, dated August 12, 2020, between the Company and Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several underwriters named therein
(Filed With SEC on August 14, 2020)
-
Employment Agreement, dated June 8, 2020, by and between the Registrant and Teresa L. Young
(Filed With SEC on July 28, 2020)
-
First Amendment to Loan and Security Agreement by and between the Registrant and Hercules Capital, Inc., dated April 16, 2020
(Filed With SEC on July 28, 2020)
-
Employment Agreement, dated April 2, 2020, by and between the Registrant and Lisa von Moltke, M.D
(Filed With SEC on May 7, 2020)
-
Letter Amendment to Employment Agreement, dated April 8, 2020, by and between the Registrant and John Aunins
(Filed With SEC on May 7, 2020)
-
Sales Agreement, dated as of March 18, 2020, between Seres Therapeutics, Inc. and Cowen and Company, LLC
(Filed With SEC on March 18, 2020)
-
Description of Capital Stock
(Filed With SEC on March 2, 2020)
-
Advisory Agreement, dated December 12, 2019, by and between the Registrant and Roger Pomerantz
(Filed With SEC on March 2, 2020)
-
Sales Agreement, dated as of November 27, 2019, between Seres Therapeutics, Inc. and Cowen and Company, LLC
(Filed With SEC on November 27, 2019)
-
Sublease Agreement dated July 1, 2019, by and between the Registrant and Flagship VL56, Inc. and Flagship VL58, Inc
(Filed With SEC on November 5, 2019)
-
Employment Agreement, dated July 11, 2019, by and between the Registrant and Marcus Chapman
(Filed With SEC on November 5, 2019)
-
Loan and Security Agreement dated October 29, 2019 between Seres Therapeutics, Inc. and Hercules Capital, Inc
(Filed With SEC on November 4, 2019)
-
Amended and Restated Employment Agreement, dated March 25, 2019, by and between the Registrant and Matthew Henn
(Filed With SEC on August 6, 2019)
-
Underwriting Agreement, dated June 13, 2019, between the Company and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters named...
(Filed With SEC on June 14, 2019)
-
Research Collaboration and Option Agreement, dated March 11, 2019, by and between the Registrant and MedImmune, LLC
(Filed With SEC on May 2, 2019)
-
Letter Agreement dated October 30, 2018, by and between the Registrant and Nestec Ltd
(Filed With SEC on March 6, 2019)
-
Amendment No 1 to the Collaboration and License Agreement, dated August 10, 2016, by and between the Registrant and Nestec Ltd
(Filed With SEC on March 6, 2019)
-
Amended and Restated Employment Agreement, dated as of January 14, 2019, by and between Seres Therapeutics, Inc. and Eric D. Shaff
(Filed With SEC on January 15, 2019)
-
Separation Agreement and Release, dated as of January 14, 2019, by and between Seres Therapeutics, Inc. and Roger Pomerantz
(Filed With SEC on January 15, 2019)